Back
ESC Premium Access

Effectiveness and safety of direct oral anticoagulants compared to vitamin-k antagonists: results from a cohort study in the nationwide french claims and hospitalisation database (SNIIRAM)

Session: Progress in stroke prevention in atrial fibrillation
Topic: Atrial fibrillation (AF)
Speaker: Professor Y. Cottin (Dijon, FR)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Professor Yves Cottin

University Hospital of Dijon, Dijon (France)
0 follower

6 more presentations in this session

Adherence to anticoagulant drugs in patients with atrial fibrillation and stroke in real clinical practice

Speaker: Professor D. Duplyakov (Samara, RU)

Access
Abstract
Slides
Like
Thumbnail

Outcomes in vitamin K antagonist treated atrial fibrillation patients with stable international normalized ratios

Speaker: Doctor A. Nissen Bonde (Gentofte, DK)

Access
Abstract
Slides
Like
Thumbnail

Periprocedural anticoagulation is associated with the risk of thromboembolism after elective cardioversion of atrial fibrillation.

Speaker: Doctor T. Hellman (Turku, FI)

Access
Abstract
Slides
Like
Thumbnail

Reduced fibrin clot permeability is associated with an increased risk of both ischemic stroke and major bleeding in atrial fibrillation patients treated with vitamin k antagonists

Speaker: Professor A. Undas (Krakow, PL)

Access
Abstract
Slides
Like
Thumbnail

The impact of age on the effectiveness and safety of the NOACs versus warfarin for stroke prevention in atrial fibrillation

Speaker: Doctor P. Noseworthy (Rochester, US)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Progress in stroke prevention in atrial fibrillation

Speakers: Professor Y. Cottin, Professor D. Duplyakov, Doctor A. Nissen Bonde, Doctor T. Hellman, Professor A. Undas...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources